RTI Surgical (NASDAQ:RTIX) Downgraded by ValuEngine to Hold

ValuEngine cut shares of RTI Surgical (NASDAQ:RTIX) from a buy rating to a hold rating in a report released on Wednesday, ValuEngine reports.

RTIX has been the subject of a number of other research reports. TheStreet cut shares of RTI Surgical from a c- rating to a d+ rating in a research report on Thursday, October 24th. Zacks Investment Research raised shares of RTI Surgical from a sell rating to a hold rating in a research report on Friday, December 27th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of Buy and an average price target of $6.13.

Shares of NASDAQ:RTIX traded down $0.22 during mid-day trading on Wednesday, reaching $4.46. 71,293 shares of the company were exchanged, compared to its average volume of 664,661. The firm has a market cap of $332.90 million, a price-to-earnings ratio of 37.21 and a beta of 1.40. The firm’s 50-day simple moving average is $2.48 and its 200 day simple moving average is $2.97. RTI Surgical has a 1 year low of $1.77 and a 1 year high of $6.15.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Thursday, October 31st. The medical equipment provider reported ($0.01) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.01). The firm had revenue of $76.13 million during the quarter. RTI Surgical had a negative net margin of 3.72% and a positive return on equity of 1.75%.

Institutional investors have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. raised its holdings in shares of RTI Surgical by 4.3% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 137,040 shares of the medical equipment provider’s stock valued at $583,000 after purchasing an additional 5,594 shares in the last quarter. Dupont Capital Management Corp grew its position in shares of RTI Surgical by 4.8% in the 3rd quarter. Dupont Capital Management Corp now owns 124,842 shares of the medical equipment provider’s stock valued at $356,000 after buying an additional 5,697 shares during the last quarter. Rhumbline Advisers grew its position in shares of RTI Surgical by 8.7% in the 3rd quarter. Rhumbline Advisers now owns 90,243 shares of the medical equipment provider’s stock valued at $257,000 after buying an additional 7,253 shares during the last quarter. Parametric Portfolio Associates LLC grew its position in shares of RTI Surgical by 20.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 47,661 shares of the medical equipment provider’s stock valued at $203,000 after buying an additional 8,104 shares during the last quarter. Finally, Wells Fargo & Company MN grew its position in shares of RTI Surgical by 11.6% in the 2nd quarter. Wells Fargo & Company MN now owns 113,200 shares of the medical equipment provider’s stock valued at $480,000 after buying an additional 11,796 shares during the last quarter. Institutional investors own 60.06% of the company’s stock.

About RTI Surgical

RTI Surgical Holdings, Inc, a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.

Featured Article: Swap

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.